companydata.dkBIODANE PHARMA A/S: Financial statements 2018
CVR: 28310102
BIODANE PHARMA A/S (CVR 28310102) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 1,010,830 and a net result of DKK -467,077 compared with DKK 102,788 the year before. That is an increase of 4.5% compared with the year before. Equity amounted to DKK 1,402,228. The solvency ratio was 95%. The company had 1 employee in the financial year.
- Gross Profit
- 1,010,830 kr.
- Profit/Loss
- -467,077 kr.
- Equity
- 1,402,228 kr.
- Total Assets
- 1,476,565 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 1 mio. | -467 t. | 1.4 mio. | 1 |
| 2017 | - | 968 t. | 103 t. | 1.9 mio. | 1 |
| 2016 | - | 747 t. | 33 t. | 767 t. | 1 |
| 2015 | - | 438 t. | -253 t. | 734 t. | - |
| 2014 | - | 279 t. | -250 t. | 987 t. | - |
Keep an eye on BIODANE PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2018
BIODANE PHARMA A/S has published its annual report for 2017. Gross profit came to DKK 967,640, and the net result was DKK 102,788.
About BIODANE PHARMA A/S
BIODANE PHARMA A/S is a Danish company of the type Aktieselskab based in Gesten, founded in 2004. The company is registered under the industry Fremstilling af andre fødevarer i.a.n.. The management consists of Gunner Kreutzer Jakobsen. The company is owned by BIODAN A/S. In 2025, the company reported a gross profit of DKK 2,534,166 and a net result of DKK 182,862 compared with DKK 1,651,356 the year before. Equity amounted to DKK 2,505,002.